Position in JANX
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$1,078,809
+$915,651 QoQ
Shares Held
70,235
+498.4% QoQ
Ownership
0.115%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#62
of 198 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JANX Over Time
Shares Held
Position Value (USD)
Derivatives in JANX
reported options exposure · as of Jun 30, 2026CallValue
$3,072
CallShares
200
PutValue
$3,072
PutShares
200
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITIGROUP INC holds $2,077,239,236 across 383 Biotechnology names. JANX ranks #141 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
706,968 | $351,172,214 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
346,637 | $216,142,034 | |
| 3 | MRNA |
Moderna, Inc.
|
2,165,414 | $151,643,941 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
2,225,190 | $78,749,472 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
227,786 | $68,570,419 | |
| 6 | INCY |
Incyte Corp
|
586,431 | $66,477,817 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
864,101 | $64,358,241 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
247,052 | $46,267,897 |
All Filings in JANX
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,072 | 200 | Put | Defined | 2026-08-03 | |
| 2026-06-30 | $3,072 | 200 | Call | Defined | 2026-08-03 | |
| 2026-06-30 | $1,078,809 | 70,235 | Shares | Defined | 2026-08-03 | |
| 2026-03-31 | $163,158 | 11,738 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $334,208 | 24,218 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $134,785 | 5,515 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $693,000 | 30,000 | Call | Defined | 2025-08-11 | |
| 2025-06-30 | $778,238 | 33,690 | Shares | Defined | 2025-08-11 | |
| 2025-06-30 | $693,000 | 30,000 | Put | Defined | 2025-08-11 | |
| 2025-03-31 | $405,000 | 15,000 | Call | Defined | 2025-05-12 | |
| 2025-03-31 | $2,059,614 | 76,282 | Shares | Defined | 2025-05-12 | |
| 2025-03-31 | $405,000 | 15,000 | Put | Defined | 2025-05-12 | |
| 2024-12-31 | $1,606,200 | 30,000 | Put | Defined | 2025-02-12 | |
| 2024-12-31 | $1,606,200 | 30,000 | Call | Defined | 2025-02-12 | |
| 2024-12-31 | $4,258,891 | 79,546 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $975,653 | 21,476 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $653,274 | 15,595 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $1,565,184 | 41,572 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $41,063 | 3,827 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $4,939 | 490 | Shares | Defined | 2023-12-06 | |
| 2023-06-30 | $68,691 | 5,787 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $6,763 | 559 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $5,228 | 397 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $13,336 | 985 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $26,263 | 2,151 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $26,529 | 1,850 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $94,388 | 4,784 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $37,960 | 1,755 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $2,163,040 | 86,695 | Shares | Defined | 2021-08-10 | |
| No filing history on record for this holder in this stock. | ||||||